The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy

• Published in: BMC cancer 2022-05, Vol.22 (1), p.491-13, Article 491
• Main Authors: Du, Ruofei, Yang, Huashan, Zhou, Huiyue, Ma, Lixia, Getu, Mikiyas Amare, Chen, Changying, Wang, Tao
• Format: Article
• Language: English
• Subjects: Adverse and side effects; Blood; C-reactive protein; Cancer therapies; Carcinoma, Non-Small-Cell Lung - complications; Carcinoma, Non-Small-Cell Lung - drug therapy; Consent; Correlation analysis; Cross-Sectional Studies; Disease; Drug therapy; Drug-Related Side Effects and Adverse Reactions - complications; Drug-Related Side Effects and Adverse Reactions - etiology; Drugs; Eczema; EGFR-TKI; Enzyme inhibitors; Epidermal growth factor; Epidermal growth factor receptors; ErbB Receptors; Health literacy; Hospitals; Humans; Interleukin 6; Literacy; Lung cancer; Lung cancer, Non-small cell; Lung Neoplasms - complications; Medical records; Medication literacy; Non-small cell lung carcinoma; NSCLC; Nutritional status; Patients; Protein Kinase Inhibitors - adverse effects; Protein-tyrosine kinase receptors; Questionnaires; Regression analysis; Risk factors; Skin; Skin adverse drug reactions; Skin diseases; Small cell lung carcinoma; Surveys; Targeted therapy; Validity
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-022-09599-w

High medication literacy is the basis of rational medication application and is essential for the management of severe adverse drug reactions. The objective of the present study was to assess the level of medication literacy and determine the association between medication literacy and skin adverse drug reactions in non-small-cell lung cancer (NSCLC) patients undergoing targeted epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy. This is a cross-sectional study conducted from May to September 2020. In total, 296 NSCLC patients undergoing targeted EGFR-TKI therapy were recruited from hospitals in Henan, China. Structured questionnaires were used to evaluate skin adverse drug reactions and medication literacy. Pearson correlation analysis and binary logistic regression analysis were carried out to identify the correlations between medication literacy and the severity of skin adverse drug reactions in the recruited patients. The research sample consisted of 296 patients with a response rate of 92.5%. The mean score of skin adverse drug reactions and the mean score of medication literacy were 1.83 ± 0.91 and 6.54 ± 2.78, respectively. In total, 188 patients (63.5%) were considered to have moderate medication literacy. According to the binary logistic regression analysis, the following factors were associated with severe skin adverse drug reactions: age (B =  - 3.929, P = 0.000), sex (B = -4.062, P = 0.000), educational level (B = 2.712, P = 0.002), comorbidity (B = 3.297, P = 0.001), eczema history (B = 2.996, P = 0.001), nutritional status (B = -4.891, P = 0.000), blood interleukin-6 level (B = -2.143, P = 0.013), blood high-sensitivity C-reactive protein level (B = -4.015, P = 0.000), combination of drugs (B = -3.183, P = 0.048) and medication literacy (B =  - 1.503, P = 0.000). Subgroup analysis showed that in addition to medication literacy, some other factors including education level, comorbidity, nutritional status, blood interleukin-6 level and combined drug application were common factors that contributed to various adverse skin drug reactions in NSCLC patients under targeted EGFR-TKI therapy. The low medication literacy of the investigated NSCLC patients undergoing targeted EGFR-TKI therapy was correlated with a high proportion of severe skin adverse drug reactions. In addition, factors other than medication literacy including education level, comorbidity, nutritional status, blood interleukin-6 level and the combinatorial